Steece-Collier K - Search Results

1

α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.

Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, Schulz E, Cole-Strauss A, Luna E, Quach D, Mohan A, Bennett CF, Swayze EE, Kordasiewicz HB, Luk KC, Paumier KL. Cole TA, et al. Among authors: steece collier k. JCI Insight. 2021 Mar 8;6(5):e135633. doi: 10.1172/jci.insight.135633. JCI Insight. 2021. PMID: 33682798 Free PMC article.

2

Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons.

Steece-Collier K, Collier TJ, Sladek CD, Sladek JR Jr. Steece-Collier K, et al. Exp Neurol. 1990 Nov;110(2):201-8. doi: 10.1016/0014-4886(90)90031-m. Exp Neurol. 1990. PMID: 2226699

3

Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K. Alexander T, et al. Cell Transplant. 1997 May-Jun;6(3):309-15. doi: 10.1177/096368979700600313. Cell Transplant. 1997. PMID: 9171163

4

Cellular models to study dopaminergic injury responses.

Collier TJ, Steece-Collier K, McGuire S, Sortwell CE. Collier TJ, et al. Ann N Y Acad Sci. 2003 Jun;991:140-51. doi: 10.1111/j.1749-6632.2003.tb07472.x. Ann N Y Acad Sci. 2003. PMID: 12846983 Review.

5

The role of alpha-synuclein in Parkinson's disease: insights from animal models.

Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. Maries E, et al. Nat Rev Neurosci. 2003 Sep;4(9):727-38. doi: 10.1038/nrn1199. Nat Rev Neurosci. 2003. PMID: 12951565 Review. No abstract available.

6

Primate models of Parkinson's disease.

Collier TJ, Steece-Collier K, Kordower JH. Collier TJ, et al. Exp Neurol. 2003 Oct;183(2):258-62. doi: 10.1016/s0014-4886(03)00246-2. Exp Neurol. 2003. PMID: 14552866 No abstract available.

7

Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.

Steece-Collier K, Collier TJ, Danielson PD, Kurlan R, Yurek DM, Sladek JR Jr. Steece-Collier K, et al. Mov Disord. 2003 Dec;18(12):1442-54. doi: 10.1002/mds.10588. Mov Disord. 2003. PMID: 14673880

8

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

Maries E, Kordower JH, Chu Y, Collier TJ, Sortwell CE, Olaru E, Shannon K, Steece-Collier K. Maries E, et al. Neurobiol Dis. 2006 Jan;21(1):165-80. doi: 10.1016/j.nbd.2005.07.002. Epub 2005 Aug 10. Neurobiol Dis. 2006. PMID: 16095907

9

Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

Kordower JH, Kanaan NM, Chu Y, Suresh Babu R, Stansell J 3rd, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ. Kordower JH, et al. Ann Neurol. 2006 Aug;60(2):264-8. doi: 10.1002/ana.20935. Ann Neurol. 2006. PMID: 16862579

10

The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

Soderstrom KE, Meredith G, Freeman TB, McGuire SO, Collier TJ, Sortwell CE, Wu Q, Steece-Collier K. Soderstrom KE, et al. Neurobiol Dis. 2008 Nov;32(2):229-42. doi: 10.1016/j.nbd.2008.06.018. Epub 2008 Jul 11. Neurobiol Dis. 2008. PMID: 18672063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page